Author

G. Llimos

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:ChIP-seq· 2 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

J. Kirk· 2 shared M. D. Long· 2 shared M. J. Campbell· 2 shared P. K. Singh· 2 shared A. M. Rowsam· 1 shared A. Meireles-Filho· 1 shared A. Rizvi· 1 shared B. Deplancke· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. Kirk

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer

M. D. Long, P. K. Singh, G. Llimos, J. J. Jacobi, A. M. Rowsam, S. R. Rosario, J. Kirk, H. C. Affronti, M. J. Campbell, D. Smiraglia

This study shows reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer by promoting DNA hypermethylation and neuroendocrine gene expression.

bioRxiv · Jul 2, 2020Cancer Biology

A highly parallel, automated platform enabling individual or sequential ChIP of histone marks and transcription factors

R. Dainese, V. Gardeux, G. Llimos, D. Alpern, J. Y. Jiang, A. Meireles-Filho, B. Deplancke

This paper introduces FloChIP, a microfluidic platform for automated ChIP-seq that improves speed, throughput, and sensitivity compared to traditional methods.

bioRxiv · Aug 7, 2019Bioengineering

The miR-96 and RAR&gamma signaling axis governs androgen signaling and prostate cancer progression

M. D. Long, P. K. Singh, J. R. Russell, G. Llimos, S. Rosario, A. Rizvi, H. Withers, P. R. van den Berg, J. Kirk, L. E. Sucheston-Campbell, D. J. Smiraglia, M. J. Campbell

This study identifies miR-96 as a regulator of RARγ expression, which in turn controls androgen signaling and prostate cancer progression through gene network alterations.

bioRxiv · Apr 26, 2018Cancer Biology